Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Genetic germ test to guide treatment of severe infections in adults with AIDS

Checks whether a genetic germ test guides treatment of severe pneumonia or sepsis in AIDS.

Plain-language title generated from the registry record
Registry title: Metagenomic Next-Generation Sequencing Guides Anti-Infection Strategies

Key facts

Where
Guangzhou, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT06145841, who can take part

Where in China

  • Linghua LiGuangzhou, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Guangzhou 8th People's Hospital
Trial code
NCT06145841
Record updated
24 November 2023
Original description
This study aims to observe the effectiveness of clinical application in guiding anti-infection treatments in AIDS patients with severe pneumonia and/or sepsis using Metagenomic Next-Generation Sequencing-based technology in the real worldRead full original descriptionShow less

Clinical Application of Metagenomic Next-Generation Sequencing-Guided Anti-Infection Strategies in AIDS Patients With Severe Pneumonia and/or Sepsis

This study aims to observe the effectiveness of clinical application in guiding anti-infection treatments in AIDS patients with severe pneumonia and/or sepsis using Metagenomic Next-Generation Sequencing-based technology in the real world

Inclusion: Confirmed HIV infection; Progression to AIDS stage: CD4+ count <200 cells/ul and/or occurrence of AIDS opportunistic infections; Age between 18 and 65 years; Meeting the diagnosis of severe pneumonia or septic shock:; The criteria for severe pneumonia diagnosis refer to the 2021 ATS (American Thoracic Society) and IDSA (Infectious Diseases Society of America) guidelines for the treatment of community-acquired pneumonia; The criteria for septic shock refer to the Chinese Society of Critical Care Medicine's "Chinese Guidelines for the Emergency Treatment of Sepsis/Septic Shock (2018).

Exclusion: Concurrent AIDS-related or unrelated tumors; Alcohol abuse or drug use; Coexisting central nervous system lesions, severe liver disease, or cirrhosis; Severe underlying diseases of the heart, lungs, liver, kidneys, etc; The researcher believes that the overall condition of the subject affects the evaluation and completion of the trial; Women who are pregnant or breastfeeding.

ClinicalTrials.gov NCT06145841